CVA Family Office’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$74.4K Sell
313
-11
-3% -$2.29K 0.01% 539
2026
Q1
$68.5K Buy
324
+114
+54% +$24.6K 0.01% 532
2025
Q4
$43.2K Buy
210
+12
+6% +$2.26K 0.01% 573
2025
Q3
$31.1K Sell
198
-17
-8% -$2.63K ﹤0.01% 620
2025
Q2
$36.1K Buy
215
+21
+11% +$3.12K 0.01% 589
2025
Q1
$26.7K Buy
194
+14
+8% +$1.78K ﹤0.01% 635
2024
Q4
$21.3K Buy
180
+41
+29% +$4.79K ﹤0.01% 667
2024
Q3
$15.4K Buy
139
+4
+3% +$418 ﹤0.01% 687
2024
Q2
$13.3K Sell
135
-5
-4% -$509 ﹤0.01% 700
2024
Q1
$15.7K Buy
140
+5
+4% +$539 ﹤0.01% 686
2023
Q4
$13.6K Buy
+135
New +$13.4K ﹤0.01% 679
2023
Q3
Sell
-155
Closed -$14.7K 337
2023
Q2
$14.7K Buy
155
+25
+19% +$2.11K ﹤0.01% 669
2023
Q1
$9.81K Hold
130
﹤0.01% 692
2022
Q4
$9.99K Hold
130
﹤0.01% 659
2022
Q3
$9K Hold
130
﹤0.01% 637
2022
Q2
$7K Hold
130
﹤0.01% 695
2022
Q1
$7K Hold
130
﹤0.01% 721
2021
Q4
$7K Buy
+130
New +$6.38K ﹤0.01% 700
2021
Q3
Sell
-185
Closed -$11K 438
2021
Q2
$11K Sell
185
-15
-8% -$876 ﹤0.01% 625
2021
Q1
$12K Buy
+200
New +$11K ﹤0.01% 495

Other funds holding CAH

CVA Family Office's CAH Position: Q2 2026 in Review

CVA Family Office reduced its Cardinal Health (CAH) stake by 3.4% in Q2 2026, selling an estimated $2.29K and leaving 313 shares worth $74.4K. The position accounts for 0.01% of the portfolio, ranked #539.

CVA Family Office first reported a position in CAH in Q1 2021 and has held it in 20 quarters since. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • CVA Family Office held 313 shares of Cardinal Health worth $74.4K as of Q2 2026.
  • CVA Family Office sold 11 Cardinal Health shares in Q2 2026, an estimated $2.29K.
  • Cardinal Health made up 0.01% of CVA Family Office's portfolio in Q2 2026, its #539 holding.
  • CVA Family Office first reported a position in Cardinal Health in Q1 2021 and has held it in 20 quarters since.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.